Immune Design (IMDZ) PT Lowered to $9 at RBC Capital

November 7, 2018 7:20 AM EST Send to a Friend

RBC Capital analyst Brian Abrahams ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Immune Design (IMDZ) PT Lowered to $9 at RBC Capital

Member Login

Free News Feed